Array BioPharma Appoints New CFO

Boulder-based Array BioPharma announced this morning that it has named Patricia Henahan as the company's new Chief Financial Officer. Henahan previously has served at Hospira, AstraZeneca, Eli Lilly and MedImmune, most recently serving as VP of Finance for Hospira's U.S., pharmaceutical-focused business. Array BioPharma is a biopharmaceuticals firm, focused on small molecule drugs for the treatment of cancer. The company is led by Ron Squarer. The company recently inked a big licensing deal with Novartis.